{"id":"NCT04447469","sponsor":"Kiniksa Pharmaceuticals International, plc","briefTitle":"Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation","officialTitle":"A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Mavrilimumab (KPL-301) Treatment in Adult Subjects Hospitalized With Severe COVID-19 Pneumonia and Hyper-inflammation","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2020-07-28","primaryCompletion":"2021-11-12","completion":"2022-01-14","firstPosted":"2020-06-25","resultsPosted":"2025-01-22","lastUpdate":"2025-01-22"},"enrollment":814,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["COVID"],"interventions":[{"type":"DRUG","name":"mavrilimumab","otherNames":["KPL-301","CAM3001"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"10 mg/kg (Cohort 1)","type":"ACTIVE_COMPARATOR"},{"label":"6 mg/kg (Cohort 1)","type":"ACTIVE_COMPARATOR"},{"label":"Placebo (Cohort 1)","type":"PLACEBO_COMPARATOR"},{"label":"10 mg/kg (Cohort 2)","type":"ACTIVE_COMPARATOR"},{"label":"6 mg/kg (Cohort 2)","type":"ACTIVE_COMPARATOR"},{"label":"Placebo (Cohort 2)","type":"PLACEBO_COMPARATOR"}],"summary":"Interventional, randomized, double-blind, placebo-controlled study encompassing 2 development phases (Phase 2 and Phase 3).","primaryOutcome":{"measure":"Cohort 1, Phase 2: Percentage of Participants Alive and Free of Mechanical Ventilation at Day 29","timeFrame":"Day 29","effectByArm":[{"arm":"Phase 2: 10 mg/kg (Cohort 1)","deltaMin":85.7,"sd":null},{"arm":"Phase 2: 6 mg/kg (Cohort 1)","deltaMin":87.5,"sd":null},{"arm":"Phase 2: Placebo (Cohort 1)","deltaMin":74.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.2598"},{"comp":"OG001 vs OG002","p":"0.1610"},{"comp":"OG000 vs OG002","p":"0.2448"},{"comp":"OG001 vs OG002","p":"0.1378"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":10},"locations":{"siteCount":32,"countries":["United States","Brazil","Chile","Peru","South Africa"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":35},"commonTop":["Constipation","Pneumonia","Hypokalaemia","Anaemia","Hypertension"]}}